# Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

> **NCT05819619** · EARLY_PHASE1 · TERMINATED · sponsor: **Hackensack Meridian Health** · enrollment: 8 (actual)

## Conditions studied

- Nausea
- Pain

## Interventions

- **DRUG:** Prophylactic use of ibuprofen and ondansetron post misoprostol administration
- **DRUG:** Use of ibuprofen and ondansetron at symptom onset post misoprostol administration

## Key facts

- **NCT ID:** NCT05819619
- **Lead sponsor:** Hackensack Meridian Health
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-07-20
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-04-11
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Inability to recruit and staffing changes
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05819619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05819619, "Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05819619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*